Home
Conditions
Carcinoma, Non-Small-Cell Lung

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,709 public trials 1,044 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Study Comparing the Efficacy and Safety Between IBI308 and Docetaxel in Patients With Advanced or Metastatic NSCLC

NCT03150875

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: The First Affiliated Hospital Zhejiang University Hangzhou, Zhejiang, China

Jiangsu Cancer Hospital Nanjing, China

View Trial Details

Completed

A Chart Review Study of Adults With Advanced NSCLC

NCT05207423

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: William Osler Health System Brampton, Ontario, Canada

Grand River Hospital Kitchener, Ontario, Canada

Ottawa Hospital Research Institute. Ottawa, Ontario, Canada

University Health Network Princess Margaret Cancer Research Tower (PMCRT) The MaRS Centre, East Tower Toronto, Ontario, Canada

View all 30 locations

View Trial Details

Completed

A PK Similarity Study of Two Sintilimab Products Produced by Different Processes in Advanced or Metastatic NSCLC Patients

NCT04177290

Conditions: Advanced or Metastatic NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations: The First Affiliated Hospital of Bengbu Medical College Bengbu, China

View Trial Details

Completed

Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study

NCT02803333

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

IBI310 (Anti-CTLA-4) in Combination With Sintilimab in Patients With Non-small-cell Lung Cancer (NSCLC)

NCT05118334

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Completed

Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy

NCT02151604

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Oxford University Hospitals NHS Trust Oxford, England, United Kingdom

View Trial Details

Completed

MEK Inhibitor and Thoracic Radiotherapy Trial

NCT01146756

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom

View Trial Details

Completed

Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]

NCT04059887

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Chonnam National University Hwasun Hospital Hwasun, Jeollanam-do, South Korea

View Trial Details

Completed

Predictive Gene Profiles and Dynamic Measurement of Treatment Response in Metastatic Non-small Cell Lung Cancer

NCT03512847

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Department of Oncology Næstved, Region Sjælland, Denmark

View Trial Details

Completed

Predicting Response to PD-1 Checkpoint Blockade Using Deep Learning Analysis of Imaging and Clinical Data

NCT05711914

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Jean-Paul BEREGI Nîmes, France

View Trial Details

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung trial results

Related conditions